The increasing prevalence of foot-related pathologies, especially among the aging population, highlights the urgent need for advanced diagnostic tools in radiology and orthopedics. Addressing this necessity, Vienna-based ImageBiopsy Lab (IB Lab) has introduced IB Lab FROG, an innovative AI-powered
The rise of artificial intelligence (A.I.) in the pharmaceutical industry signifies a transformative period, placing unprecedented power in the hands of tech-driven drug discovery and igniting debates about innovation, control, and patient safety. Subject to regulatory scrutiny, the FDA has
Insilico Medicine, an AI-based drug developer, has made significant strides with its lead candidate, ISM001-055, in the treatment of idiopathic pulmonary fibrosis (IPF). Following promising results from a Phase IIa trial, the company is now gearing up for potentially pivotal clinical trials that
Artificial Intelligence (AI) has emerged as a transformative force in numerous sectors, and nowhere is its impact more pronounced than in the field of drug discovery. This field, traditionally marked by high costs, time-consuming processes, and a significant amount of trial and error, is witnessing
Medical imaging has undergone significant transformations over the years, and artificial intelligence (AI) has emerged rapidly as a game-changer in this field. Traditionally, medical imaging techniques like X-rays, MRI, and CT scans have been vital for diagnosing various conditions. However, with
The European Union stands on the cusp of a transformative phase in healthcare, propelled by DigitalEurope’s strategic advisory paper. Issued with a sense of urgency and foresight, the paper sketches a digital health policy framework that will redefine the delivery of healthcare from 2024 to 2029. A
